|
EmbolexDrug - Embolex The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Dihydroergotamine Mesylate; Heparin Sodium; Lidocaine Hydrochloride
Strength -
0.5MG/0.7ML;5,000 UNITS/0.7ML;7.46MG/0.7ML
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
018885
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 30, 1984
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Embolex
Lanoxin 0.5mg Tablet; Oral
D.H.E. 45 1mg/ml Injectable; Injection Dihydroergotamine Mesylate 1mg/ml Injectable; Injection Dihydroergotamine Mesylate 1mg/ml Injectable; Injection Migranal 0.5mg/inh Spray, Metered; Nasal Embolex 0.5mg/0.5ml;2,500 Units/0.5ml;5.33mg/0.5ml Injectable; Injection Embolex 0.5mg/0.7ml;5,000 Units/0.7ml;7.46mg/0.7ml Injectable; Injection Lanoxin 0.1875mg Tablet; Oral Lanoxin 0.25mg Tablet; Oral Lanoxin 0.375mg Tablet; Oral NewDrugInformation |